Skip to main content
Erschienen in: Endocrine 3/2015

01.08.2015 | Original Article

Localization of the aromatase enzyme expression in the human pituitary gland and its effect on growth hormone, prolactin, and thyroid stimulating hormone axis

verfasst von: Asli Sezgin Caglar, Aysegul Kapucu, Kadriye Akgun Dar, Hande Mefkure Ozkaya, Erkan Caglar, Haluk Ince, Pinar Kadioglu

Erschienen in: Endocrine | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study is to evaluate aromatase expression in prolactin (PRL), thyroid stimulating hormone (TSH), and growth hormone (GH) secreting cells. Nontumoral human pituitary specimens were obtained from autopsy samples. Aromatase co-expression was determined by double immunohistochemical staining and assessed using H scores. H scores for GH-aromatase co-expression (GH-aromatase), TSH-aromatase co-expression (TSH-aromatase), and PRL-aromatase co-expression (PRL-aromatase) were 83.1 ± 13.1, 95.6 ± 16.1, and 83.7 ± 14.5, respectively. TSH producing cells exhibited the highest H score for co-expression of aromatase (p < 0.001). There was no gender difference in terms of H scores for aromatase expression and double immunohistochemical staining results (p > 0.05 for all). There was a negative correlation between the H scores for aromatase and PRL-aromatase, GH-aromatase and TSH-aromatase, respectively (r = −0.592, p < 0.001; r = −0.593, p < 0.001; r = −0.650, p < 0.001, respectively). Also, H scores for aromatase co-expression of each hormone were negatively correlated with the H scores for the corresponding hormone (r = −0.503, p < 0.001 for PRL-aromatase and PRL; r = −0.470, p < 0.001 for GH-aromatase, and GH; r = −0.641, p < 0.001 for TSH-aromatase and TSH). H scores for mean aromatase, GH-aromatase, TSH-aromatase were invariant of age (p > 0.05 for all). Age was negatively correlated with PRL-aromatase H score (r = −0.373, p = 0.008). Our study demonstrated significant aromatase co-expression in PRL, GH, and TSH secreting cells of the human anterior pituitary gland. The mutual paracrinal regulation between aromatase and three adenohypophyseal hormones indicates that aromatase may have a regulatory role on the synthesis and secretion of these hormones.
Literatur
1.
Zurück zum Zitat I. Czajka-Oraniec, E.R. Simpson, Aromatase research and its clinical significance. Endokrynol. Pol. 61, 126–134 (2010)PubMed I. Czajka-Oraniec, E.R. Simpson, Aromatase research and its clinical significance. Endokrynol. Pol. 61, 126–134 (2010)PubMed
2.
Zurück zum Zitat L. Zirilli, V. Rochira, C. Diazzi, G. Caffagni, C. Carani, Human models of aromatase deficiency. J. Steroid Biochem. Mol. Biol. 109, 212–218 (2008)PubMedCrossRef L. Zirilli, V. Rochira, C. Diazzi, G. Caffagni, C. Carani, Human models of aromatase deficiency. J. Steroid Biochem. Mol. Biol. 109, 212–218 (2008)PubMedCrossRef
3.
Zurück zum Zitat E. Simpson, G. Rubin, C. Clyne, K. Robertson, L. O’Donnell, S. Davis, M. Jones, Local estrogen biosynthesis in males and females. Endocr. Relat. Cancer 6, 131–137 (1999)PubMedCrossRef E. Simpson, G. Rubin, C. Clyne, K. Robertson, L. O’Donnell, S. Davis, M. Jones, Local estrogen biosynthesis in males and females. Endocr. Relat. Cancer 6, 131–137 (1999)PubMedCrossRef
4.
Zurück zum Zitat C.F. Singer, A. Fink-Retter, D. Gschwantler-Kaulich, T. Thalhammer, G. Hudelist, R. Mueller, K. Czerwenka, E. Kubista, Selective spatial upregulation of intratumoral stromal aromatase in breast cancer patients: evidence for imbalance of local estrogen metabolism. Endocr. Relat. Cancer 13, 1101–1107 (2006)PubMedCrossRef C.F. Singer, A. Fink-Retter, D. Gschwantler-Kaulich, T. Thalhammer, G. Hudelist, R. Mueller, K. Czerwenka, E. Kubista, Selective spatial upregulation of intratumoral stromal aromatase in breast cancer patients: evidence for imbalance of local estrogen metabolism. Endocr. Relat. Cancer 13, 1101–1107 (2006)PubMedCrossRef
5.
Zurück zum Zitat C.G. Leães, R.T. Meurer, L.B. Coutinho, N.P. Ferreira, J.F. Pereira-Lima, M. da Costa, Oliveira, Immunohistochemical expression of aromatase and estrogen, androgen and progesterone receptors in normal and neoplastic human meningeal cells. Neuropathology 30, 44–49 (2010)PubMedCrossRef C.G. Leães, R.T. Meurer, L.B. Coutinho, N.P. Ferreira, J.F. Pereira-Lima, M. da Costa, Oliveira, Immunohistochemical expression of aromatase and estrogen, androgen and progesterone receptors in normal and neoplastic human meningeal cells. Neuropathology 30, 44–49 (2010)PubMedCrossRef
6.
Zurück zum Zitat S. Montelli, A. Peruffo, P. Zambenedetti, E. Rossipal, M. Giacomello, P. Zatta, B. Cozzi, Expression of aromatase P450 (AROM) in the human fetal and early postnatal cerebral cortex. Brain Res. 1475, 11–18 (2012)PubMedCrossRef S. Montelli, A. Peruffo, P. Zambenedetti, E. Rossipal, M. Giacomello, P. Zatta, B. Cozzi, Expression of aromatase P450 (AROM) in the human fetal and early postnatal cerebral cortex. Brain Res. 1475, 11–18 (2012)PubMedCrossRef
7.
Zurück zum Zitat I. Azcoitia, J.G. Yague, L.M. Garcia-Segura, Estradiol synthesis within the human brain. Neuroscience 191, 139–147 (2011)PubMedCrossRef I. Azcoitia, J.G. Yague, L.M. Garcia-Segura, Estradiol synthesis within the human brain. Neuroscience 191, 139–147 (2011)PubMedCrossRef
8.
Zurück zum Zitat G.E. Gillies, S. McArthur, Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines. Pharmacol. Rev. 62, 155–198 (2010)PubMedCentralPubMedCrossRef G.E. Gillies, S. McArthur, Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines. Pharmacol. Rev. 62, 155–198 (2010)PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat J. Carretero, G. Vázquez, E. Blanco, M. Rubio, M. Santos, A. Martín-Clavijo, J.L. Torres, R. Vazquez, Immunohistochemical evidence of the presence of aromatase P450 in the rat hypophysis. Cell Tissue Res. 295, 419–423 (1999)PubMedCrossRef J. Carretero, G. Vázquez, E. Blanco, M. Rubio, M. Santos, A. Martín-Clavijo, J.L. Torres, R. Vazquez, Immunohistochemical evidence of the presence of aromatase P450 in the rat hypophysis. Cell Tissue Res. 295, 419–423 (1999)PubMedCrossRef
10.
Zurück zum Zitat P. Kadioglu, G. Oral, M. Sayitoglu, N. Erensoy, B. Senel, N. Gazioglu, A. Sav, G. Cetin, U. Ozbek, Aromatase cytochrome P450 enzyme expression in human pituitary. Pituitary 11, 29–35 (2008)PubMedCrossRef P. Kadioglu, G. Oral, M. Sayitoglu, N. Erensoy, B. Senel, N. Gazioglu, A. Sav, G. Cetin, U. Ozbek, Aromatase cytochrome P450 enzyme expression in human pituitary. Pituitary 11, 29–35 (2008)PubMedCrossRef
11.
Zurück zum Zitat S. Wickman, L. Dunkel, Inhibition of P450 aromatase enchances gonadotropin secretion in early and midpubertal boys: evidence for a pituitary site of action of endogenous E. J. Clin. Endocrinol. Metab. 86, 4887–4894 (2001)PubMedCrossRef S. Wickman, L. Dunkel, Inhibition of P450 aromatase enchances gonadotropin secretion in early and midpubertal boys: evidence for a pituitary site of action of endogenous E. J. Clin. Endocrinol. Metab. 86, 4887–4894 (2001)PubMedCrossRef
12.
Zurück zum Zitat J.F. Couse, K.S. Korach, Estrogen receptor null mice: what have we learned and where will they lead us? Endocr. Rev. 20, 358–417 (1999)PubMedCrossRef J.F. Couse, K.S. Korach, Estrogen receptor null mice: what have we learned and where will they lead us? Endocr. Rev. 20, 358–417 (1999)PubMedCrossRef
13.
Zurück zum Zitat V. Rochira, A. Balestrieri, M. Faustini-Fustini, S. Borgato, P. Beck-Peccoz, C. Carani, Pituitary function in a man with congenital aromatase deficiency: effect of different doses of transdermal E2 on basal and stimulated pituitary hormones. J. Clin. Endocrinol. Metab. 87, 2857–2862 (2002)PubMedCrossRef V. Rochira, A. Balestrieri, M. Faustini-Fustini, S. Borgato, P. Beck-Peccoz, C. Carani, Pituitary function in a man with congenital aromatase deficiency: effect of different doses of transdermal E2 on basal and stimulated pituitary hormones. J. Clin. Endocrinol. Metab. 87, 2857–2862 (2002)PubMedCrossRef
14.
Zurück zum Zitat N. Pitteloud, A.A. Dwyer, S. DeCruz, H. Lee, P.A. Boepple, W.F. Crowley Jr, F.J. Hayes, Inhibition of luteinizing hormone secretion by testosterone in men requires aromatization for its pituitary but not its hypothalamic effects: evidence from the tandem study of normal and gonadotropin-releasing hormone-deficient men. J. Clin. Endocrinol. Metab. 93, 784–791 (2008)PubMedCentralPubMedCrossRef N. Pitteloud, A.A. Dwyer, S. DeCruz, H. Lee, P.A. Boepple, W.F. Crowley Jr, F.J. Hayes, Inhibition of luteinizing hormone secretion by testosterone in men requires aromatization for its pituitary but not its hypothalamic effects: evidence from the tandem study of normal and gonadotropin-releasing hormone-deficient men. J. Clin. Endocrinol. Metab. 93, 784–791 (2008)PubMedCentralPubMedCrossRef
15.
Zurück zum Zitat M. Yan, M.E. Jones, M. Hernandez, D. Liu, E.R. Simpson, C. Chen, Functional modification of pituitary somatotropes in the aromatase knockout mouse and the effect of estrogen replacement. Endocrinology 145, 604–612 (2004)PubMedCrossRef M. Yan, M.E. Jones, M. Hernandez, D. Liu, E.R. Simpson, C. Chen, Functional modification of pituitary somatotropes in the aromatase knockout mouse and the effect of estrogen replacement. Endocrinology 145, 604–612 (2004)PubMedCrossRef
16.
Zurück zum Zitat M.E. Freeman, B. Kanyicska, A. Lerant, G. Nagy, Prolactin: structure, function, and regulation of secretion. Physiol. Rev. 80, 1523–1631 (2000)PubMed M.E. Freeman, B. Kanyicska, A. Lerant, G. Nagy, Prolactin: structure, function, and regulation of secretion. Physiol. Rev. 80, 1523–1631 (2000)PubMed
17.
Zurück zum Zitat D. Prager, G.D. Braunstein, Pituitary disorders during pregnancy. Endocrinol. Metab. Clin. North Am. 24, 1–14 (1995)PubMed D. Prager, G.D. Braunstein, Pituitary disorders during pregnancy. Endocrinol. Metab. Clin. North Am. 24, 1–14 (1995)PubMed
18.
Zurück zum Zitat E.A. Rakha, S.E. El-Sheikh, M.A. Kandil, M.E. El-Sayed, A.R. Green, I.O. Ellis, Expression Of Brca1 protein in breast cancer and its prognostic significance. Human Pathol. 39, 857–865 (2008)CrossRef E.A. Rakha, S.E. El-Sheikh, M.A. Kandil, M.E. El-Sayed, A.R. Green, I.O. Ellis, Expression Of Brca1 protein in breast cancer and its prognostic significance. Human Pathol. 39, 857–865 (2008)CrossRef
19.
Zurück zum Zitat H. Sasano, K. Takashashi, F. Satoh, H. Nagura, N. Harada, Aromatase in the human central nervous system. Clin Endocrinol (Oxf). 48, 325–329 (1998)PubMedCrossRef H. Sasano, K. Takashashi, F. Satoh, H. Nagura, N. Harada, Aromatase in the human central nervous system. Clin Endocrinol (Oxf). 48, 325–329 (1998)PubMedCrossRef
20.
Zurück zum Zitat M.J. Garcia Barrado, E.J. Blanco, M. Carretero Hernandez, M.C. Iglesias Osma, M. Carretero, J.J. Herrero, D.J. Burks, J. Carretero, Local transformation of androgens into estradiol by aromatase P450 is involved in the regulation of prolactin and the percentage of pituitary prolactin positive cells. PLoS ONE 9, e101403 (2014)PubMedCentralPubMedCrossRef M.J. Garcia Barrado, E.J. Blanco, M. Carretero Hernandez, M.C. Iglesias Osma, M. Carretero, J.J. Herrero, D.J. Burks, J. Carretero, Local transformation of androgens into estradiol by aromatase P450 is involved in the regulation of prolactin and the percentage of pituitary prolactin positive cells. PLoS ONE 9, e101403 (2014)PubMedCentralPubMedCrossRef
21.
Zurück zum Zitat J. Carretero, D.J. Burks, G. Vázquez, M. Rubio, E. Hernández, P. Bodego, R. Vázquez, Expression of aromatase P450 is increased in spontaneous prolactinomas of aged rats. Pituitary 5, 5–10 (2002)PubMedCrossRef J. Carretero, D.J. Burks, G. Vázquez, M. Rubio, E. Hernández, P. Bodego, R. Vázquez, Expression of aromatase P450 is increased in spontaneous prolactinomas of aged rats. Pituitary 5, 5–10 (2002)PubMedCrossRef
22.
Zurück zum Zitat H. Akinci, A. Kapucu, K.A. Dar, O. Celik, B. Tutunculer, G. Sirin, B. Oz, N. Gazioglu, H. Ince, S. Aliustaoglu, P. Kadioglu, Aromatase cytochrome P450 enzyme expression in prolactinomas and its relationship to tumor behavior. Pituitary 16, 386–392 (2013)PubMedCrossRef H. Akinci, A. Kapucu, K.A. Dar, O. Celik, B. Tutunculer, G. Sirin, B. Oz, N. Gazioglu, H. Ince, S. Aliustaoglu, P. Kadioglu, Aromatase cytochrome P450 enzyme expression in prolactinomas and its relationship to tumor behavior. Pituitary 16, 386–392 (2013)PubMedCrossRef
23.
Zurück zum Zitat A. Selek, B. Cetinarslan, Y. Gurbuz, I. Tarkun, Z. Canturk, B. Cabuk, Aromatase enzyme expression in acromegaly and its possible relationship with disease prognosis. Endocrine (2014). doi:10.1007/s12020-014-0445-1 PubMed A. Selek, B. Cetinarslan, Y. Gurbuz, I. Tarkun, Z. Canturk, B. Cabuk, Aromatase enzyme expression in acromegaly and its possible relationship with disease prognosis. Endocrine (2014). doi:10.​1007/​s12020-014-0445-1 PubMed
24.
Zurück zum Zitat R.L. Jakap, T.L. Horvath, C. Leranth, N. Harada, F. Naftolin, Aromatase immunoreactivity in the rat brain: gonadectomy-sensitive hypothalamic neurons and an unresponsive “limbic ring” of the lateral septum-bed nucleus-amygdala complex. J. Steroid Biochem. Mol. Biol. 44, 481–498 (1993)CrossRef R.L. Jakap, T.L. Horvath, C. Leranth, N. Harada, F. Naftolin, Aromatase immunoreactivity in the rat brain: gonadectomy-sensitive hypothalamic neurons and an unresponsive “limbic ring” of the lateral septum-bed nucleus-amygdala complex. J. Steroid Biochem. Mol. Biol. 44, 481–498 (1993)CrossRef
25.
Zurück zum Zitat T. Suzuki, H. Sasano, H. Sasaki, T. Fukaya, H. Nagura, Quantitation of P450 aromatase immunoreactivity in human ovary during the menstrual cycle: relationship between the enzyme activity and immunointensity. J. Histochem. Cytochem. 42, 1565–1573 (1994)PubMedCrossRef T. Suzuki, H. Sasano, H. Sasaki, T. Fukaya, H. Nagura, Quantitation of P450 aromatase immunoreactivity in human ovary during the menstrual cycle: relationship between the enzyme activity and immunointensity. J. Histochem. Cytochem. 42, 1565–1573 (1994)PubMedCrossRef
26.
Zurück zum Zitat J.S. Krasnow, G.J. Hickey, J.S. Richards, Regulation of aromatase mRNA and estradiol biosynthesis in rat ovarian granulosa and luteal cells by prolactin. Mol. Endocrinol. 4, 13–21 (1990)PubMedCrossRef J.S. Krasnow, G.J. Hickey, J.S. Richards, Regulation of aromatase mRNA and estradiol biosynthesis in rat ovarian granulosa and luteal cells by prolactin. Mol. Endocrinol. 4, 13–21 (1990)PubMedCrossRef
27.
Zurück zum Zitat G.J. Hickey, R.B. Oonk, P.F. Hall, J.S. Richards, Aromatase cytochrome P450 and cholesterol side-chain cleavage cytochrome P450 in corpora lutea of pregnant rats: diverse regulation by peptide and steroid hormones. Endocrinology 125, 1673–1682 (1989)PubMedCrossRef G.J. Hickey, R.B. Oonk, P.F. Hall, J.S. Richards, Aromatase cytochrome P450 and cholesterol side-chain cleavage cytochrome P450 in corpora lutea of pregnant rats: diverse regulation by peptide and steroid hormones. Endocrinology 125, 1673–1682 (1989)PubMedCrossRef
28.
Zurück zum Zitat M.L. Batrinos, The aging of the endocrine hypothalamus and its dependent endocrine glands. Hormones (Athens) 11, 241–253 (2012)CrossRef M.L. Batrinos, The aging of the endocrine hypothalamus and its dependent endocrine glands. Hormones (Athens) 11, 241–253 (2012)CrossRef
29.
Zurück zum Zitat F. Roelfsema, H. Pijl, M.D. Keenan, D.J. Veldhuis, Prolactin secretion in healthy adults is determined by gender, age and body mass index. PLoS ONE 7, e31305 (2012)PubMedCentralPubMedCrossRef F. Roelfsema, H. Pijl, M.D. Keenan, D.J. Veldhuis, Prolactin secretion in healthy adults is determined by gender, age and body mass index. PLoS ONE 7, e31305 (2012)PubMedCentralPubMedCrossRef
30.
Zurück zum Zitat A. Iranmanesh, T. Mulligan, J.D. Veldhuis, Mechanisms subserving the physiological nocturnal relative hypoprolactinemia of healthy older men: dual decline in prolactin secretory burst mass and basal release with preservation of pulse duration, frequency, and interpulse interval. J. Clin. Endocrinol. Metab. 84, 1083–1090 (1999)PubMed A. Iranmanesh, T. Mulligan, J.D. Veldhuis, Mechanisms subserving the physiological nocturnal relative hypoprolactinemia of healthy older men: dual decline in prolactin secretory burst mass and basal release with preservation of pulse duration, frequency, and interpulse interval. J. Clin. Endocrinol. Metab. 84, 1083–1090 (1999)PubMed
31.
Zurück zum Zitat S. Takahashi, S. Kawashima, H. Seo, N. Matsui, Age-related changes in growth hormone and prolactin messenger RNA levels in the rat. Endocrinol Jpn. 37, 827–840 (1990)PubMedCrossRef S. Takahashi, S. Kawashima, H. Seo, N. Matsui, Age-related changes in growth hormone and prolactin messenger RNA levels in the rat. Endocrinol Jpn. 37, 827–840 (1990)PubMedCrossRef
32.
Zurück zum Zitat J.D. Veldhuis, K.L. Mielke, M. Cosma, C. Soares-Welch, R. Paulo, J.M. Miles, C.Y. Bowers, Aromatase and 5alpha-reductase inhibition during an exogenous testosterone clamp unveils selective sex steroid modulation of somatostatin and growth hormone secretagogue actions in healthy older men. J. Clin. Endocrinol. Metab. 94, 973–981 (2009)PubMedCentralPubMedCrossRef J.D. Veldhuis, K.L. Mielke, M. Cosma, C. Soares-Welch, R. Paulo, J.M. Miles, C.Y. Bowers, Aromatase and 5alpha-reductase inhibition during an exogenous testosterone clamp unveils selective sex steroid modulation of somatostatin and growth hormone secretagogue actions in healthy older men. J. Clin. Endocrinol. Metab. 94, 973–981 (2009)PubMedCentralPubMedCrossRef
33.
Zurück zum Zitat V. Birzniece, S. Sutanto, K.K. Ho, Gender difference in the neuroendocrine regulation of growth hormone axis by selective estrogen receptor modulators. J. Clin. Endocrinol. Metab. 97, E521–E527 (2012)PubMedCrossRef V. Birzniece, S. Sutanto, K.K. Ho, Gender difference in the neuroendocrine regulation of growth hormone axis by selective estrogen receptor modulators. J. Clin. Endocrinol. Metab. 97, E521–E527 (2012)PubMedCrossRef
34.
Zurück zum Zitat A.J. Weissberger, K.K. Ho, Activation of the somatotropic axis by testosterone in adult males: evidence for the role of aromatization. J. Clin. Endocrinol. Metab. 76, 1407–1412 (1993)PubMed A.J. Weissberger, K.K. Ho, Activation of the somatotropic axis by testosterone in adult males: evidence for the role of aromatization. J. Clin. Endocrinol. Metab. 76, 1407–1412 (1993)PubMed
35.
Zurück zum Zitat J.D. Veldhuis, D.L. Metzger, P.M. Martha Jr, N. Mauras, J.R. Kerrigan, B. Keenan, A.D. Rogol, S.M. Pincus, Estrogen and testosterone, but not a nonaromatizable androgen, direct network integration of the hypothalamo-somatotrope (growth hormone)-insulin-like growth factor I axis in the human: evidence from pubertal pathophysiology and sex-steroid hormone replacement. J. Clin. Endocrinol. Metab. 82, 3414–3420 (1997)PubMed J.D. Veldhuis, D.L. Metzger, P.M. Martha Jr, N. Mauras, J.R. Kerrigan, B. Keenan, A.D. Rogol, S.M. Pincus, Estrogen and testosterone, but not a nonaromatizable androgen, direct network integration of the hypothalamo-somatotrope (growth hormone)-insulin-like growth factor I axis in the human: evidence from pubertal pathophysiology and sex-steroid hormone replacement. J. Clin. Endocrinol. Metab. 82, 3414–3420 (1997)PubMed
36.
Zurück zum Zitat A.J. Weissberger, K.K. Ho, L. Lazarus, Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J. Clin. Endocrinol. Metab. 72, 374–381 (1991)PubMedCrossRef A.J. Weissberger, K.K. Ho, L. Lazarus, Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J. Clin. Endocrinol. Metab. 72, 374–381 (1991)PubMedCrossRef
37.
Zurück zum Zitat V. Birzniece, A. Sata, S. Sutanto, K.K. Ho, Paracrine regulation of growth hormone secretion by estrogen in women. J. Clin. Endocrinol. Metab. 95, 3771–3776 (2010)PubMedCrossRef V. Birzniece, A. Sata, S. Sutanto, K.K. Ho, Paracrine regulation of growth hormone secretion by estrogen in women. J. Clin. Endocrinol. Metab. 95, 3771–3776 (2010)PubMedCrossRef
38.
Zurück zum Zitat M. Böttner, W. Wuttke, Chronic treatment with low doses of estradiol affects pituitary and thyroid function in young and middle-aged ovariectomized rats. Biogerontology 6, 261–269 (2005)PubMedCrossRef M. Böttner, W. Wuttke, Chronic treatment with low doses of estradiol affects pituitary and thyroid function in young and middle-aged ovariectomized rats. Biogerontology 6, 261–269 (2005)PubMedCrossRef
39.
Zurück zum Zitat S.A. D’Angelo, J.S. Fisher, Influence of estrogen on the pituitary-thyroid system of the female rat: mechanisms and loci of action. Endocrinology 84, 117–122 (1969)PubMedCrossRef S.A. D’Angelo, J.S. Fisher, Influence of estrogen on the pituitary-thyroid system of the female rat: mechanisms and loci of action. Endocrinology 84, 117–122 (1969)PubMedCrossRef
40.
Zurück zum Zitat H.J. Chen, P.G. Walfish, Effects of estradiol benzoate on thyroid-pituitary function in female rats. Endocrinology 103, 1023–1030 (1978)PubMedCrossRef H.J. Chen, P.G. Walfish, Effects of estradiol benzoate on thyroid-pituitary function in female rats. Endocrinology 103, 1023–1030 (1978)PubMedCrossRef
41.
Zurück zum Zitat J.S. Fisher, S.A. D’Angelo, Stimulatory and inhibitory action of estradiol on TSH secretion. Endocrinology 88, 687–691 (1971)PubMedCrossRef J.S. Fisher, S.A. D’Angelo, Stimulatory and inhibitory action of estradiol on TSH secretion. Endocrinology 88, 687–691 (1971)PubMedCrossRef
42.
Zurück zum Zitat B. Sosić-JurJević, B. Filipović, V. Milosević, N. Nestorović, M. Manojlović-Stojanoski, B. Brkić, M. Sekulić, Chronic estradiol exposure modulates thyroid structure and decreases T4 and T3 serum levels in middle-aged female rats. 63 63, 48–54 (2005) B. Sosić-JurJević, B. Filipović, V. Milosević, N. Nestorović, M. Manojlović-Stojanoski, B. Brkić, M. Sekulić, Chronic estradiol exposure modulates thyroid structure and decreases T4 and T3 serum levels in middle-aged female rats. 63 63, 48–54 (2005)
43.
Zurück zum Zitat A. Donda, F. Reymond, F. Rey, T. Lemarchand-Béraud, Sex steroids modulate the pituitary parameters involved in the regulation of TSH secretion in the rat. Acta Endocrinol (Copenh). 122, 577–584 (1990)PubMed A. Donda, F. Reymond, F. Rey, T. Lemarchand-Béraud, Sex steroids modulate the pituitary parameters involved in the regulation of TSH secretion in the rat. Acta Endocrinol (Copenh). 122, 577–584 (1990)PubMed
44.
Zurück zum Zitat S. Catalano, V. Pezzi, A. Chimento, C. Giordano, A. Carpino, M. Young, M.J. McPhaul, S. Andò, Triiodothyronine decreases the activity of the proximal promoter (PII) of the aromatase gene in the mouse Sertoli cell line, TM4. Mol. Endocrinol. 17, 923–934 (2003)PubMedCrossRef S. Catalano, V. Pezzi, A. Chimento, C. Giordano, A. Carpino, M. Young, M.J. McPhaul, S. Andò, Triiodothyronine decreases the activity of the proximal promoter (PII) of the aromatase gene in the mouse Sertoli cell line, TM4. Mol. Endocrinol. 17, 923–934 (2003)PubMedCrossRef
45.
Zurück zum Zitat N.U. Samarajeewa, F. Yang, M.M. Docanto, M. Sakurai, K.M. McNamara, H. Sasano, S.B. Fox, E.R. Simpson, K.A. Brown, HIF-1α stimulates aromatase expression driven by prostaglandin E2 in breast adipose stroma. Breast Cancer Res. 15, R30 (2013)PubMedCentralPubMedCrossRef N.U. Samarajeewa, F. Yang, M.M. Docanto, M. Sakurai, K.M. McNamara, H. Sasano, S.B. Fox, E.R. Simpson, K.A. Brown, HIF-1α stimulates aromatase expression driven by prostaglandin Ein breast adipose stroma. Breast Cancer Res. 15, R30 (2013)PubMedCentralPubMedCrossRef
Metadaten
Titel
Localization of the aromatase enzyme expression in the human pituitary gland and its effect on growth hormone, prolactin, and thyroid stimulating hormone axis
verfasst von
Asli Sezgin Caglar
Aysegul Kapucu
Kadriye Akgun Dar
Hande Mefkure Ozkaya
Erkan Caglar
Haluk Ince
Pinar Kadioglu
Publikationsdatum
01.08.2015
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 3/2015
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-015-0537-6

Weitere Artikel der Ausgabe 3/2015

Endocrine 3/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.